English | 简体中文 | 繁體中文 | 한국어 | 日本語
Sunday, 25 November 2018, 17:00 HKT/SGT
Share:
    

Source: NMRA OIC First Meeting 2018
OIC Medicines Authorities committed to cooperating toward Safe, Efficacious and Standardized Medicines and Vaccine Self-Reliance
- First Meeting of OIC NMRAs concludes in the Jakarta Declaration

JAKARTA, Nov 25, 2018 - (ACN Newswire) - The heads of National Medicines Authorities (NMRA) from the Organization of Islamic Cooperation (OIC) announced the Jakarta Declaration during their first meeting, held here November 21-22. The declaration contains, among others, efforts to harmonize standards of vaccine and self-reliance in medicines, and intensify cooperation between OIC NMRA members.

First Meeting, Heads of NMRAs of OIC Member States, Jakarta 21-2/11/2018.

NMRA Heads from OIC Member States, First Meeting, group photo, Jakarta 22/11/2018.

Indonesian Health Minister Nila F Moeloek (3rd rt) Head, National Agency of Drug & Food Control (BPOM) Penny K Lukito (2nd rt), Meeting of Heads, OIC NMRAs, Jakarta 21/11/2018. (ANTARA/WAHYU PUTRO A)

The declaration emphasizes enhanced health levels and the well being of member communities with self-reliance on the production and assured access to safe and efficacious medicines and vaccine, and increased production capacity through innovation and the development of domestic medicine and vaccine industries.

"The Jakarta Declaration is the commitment from OIC NMRAs to work together, towards the Action Plan and its various programs fostering self-reliance. With the diversity of conditions in the OIC, it is our duty to help each other in improving the capacity of regulators and the pharma industries to strengthen aspects of access to safe, quality medicines and vaccines," said Penny K. Lukito, Head of Indonesia's National Agency of Drug and Food Control (BPOM).

"We are thankful to all participants in the meeting, and the collaboration between OIC Member States. The Jakarta Declaration and Action Plan to promote collaboration are proof of unity and solidarity between the OIC Member State NMRAs towards self-sustaining health developments," she said.

The meeting addressed various issues surrounding medicines and vaccines, including regulatory status and role of regulatory authorities in ensuring drug quality and availability, efforts at the harmonization of medicine and vaccine standards towards achieving self-reliance, experiences from members regarding halal medicines and vaccines, and NMRA role in the control of counterfeit medicines and vaccines.

The members agreed to improve cooperation between NMRAs through greater exchange of information and increasing the capacity of human resources to strengthen detection, prevention, and response towards counterfeit and substandard medicines and vaccines, adopting an 'OIC Action Plan to promote collaboration among OIC NMRAs for self-reliance in Medicines and Vaccines'.

The membership was also in support of a BPOM suggestion to form a steering committee and working groups which would further discuss the central issues of halal medicine and standards for harmonization.

Then after 2 days of discussions, passage of the Jakarta Declaration, which noted with concern that many countries, including OIC Member States, have insufficient or no pharma manufacturing capabilities, or a local industry which produces but a fraction of demand, so heavy reliance on imports and medicinal aid.

Main OIC Meeting 2018 website : https://www.pom.go.id/nmra-oicmeeting2018/
Side NMRA OIC Events website : https://sideevents.nmra-oic1stmeeting.com/
Indonesian BPOM English website : https://www.pom.go.id/new/home/en/


Topic: Trade Show or Conference
Source: NMRA OIC First Meeting 2018

Sectors: BioTech, Healthcare & Pharm, ASEAN, Government
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion  
Friday, December 12, 2025 10:15:00 PM
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten  
Dec 12, 2025 14:35 HKT/SGT
Anime Tokyo Station: A Series of Linked Events to Be Held in Conjunction with the Anniversary Joint Exhibition  
Friday, December 12, 2025 10:00:00 AM
CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China  
Dec 11, 2025 20:00 HKT/SGT
Focus Graphite Achieves 99.9996 wt.% Ultra-High Purity and 2.03 ppm EBC in Follow-On Testing  
Dec 11, 2025 18:09 HKT/SGT
Nasdaq Verafin Joins Global Anti-Scam Alliance  
Dec 11, 2025 14:21 HKT/SGT
Dr. Teck Lim Chia, Chairman and CEO of CBL International, Honored at the Prestigious Directors of the Year Awards  
Dec 11, 2025 12:54 HKT/SGT
Cloudbreak Pharma Soars 80%+ on Multiple Catalysts, Driving Value Re-Rating  
Dec 11, 2025 08:20 HKT/SGT
Indonesian Government's Swift Response in Recovering Flood-hit Sumatra  
Dec 10, 2025 23:30 HKT/SGT
TIS Helps Treasury Teams Navigate the Ongoing ISO 20022 Transition After the 2025 Banking Deadline  
Dec 10, 2025 21:00 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575